Analysts fret about DRL’s prospects, slash targets
The Hyderabad-based pharma major was the biggest loser on the bourses with trading volume rising nearly 10 times after a majority of the analysts slashed their price targets. The stock made an intraday low of ₹4,524.05 apiece in Thursday’s trading before closing at ₹4,532, down 6.9%.
